title: What is changing in radiotherapy for the treatment of locally advanced nonsmall cell lung cancer patients? A review.
abstract: Radiotherapy treatment continues to have a relevant impact in the treatment of nonsmall cell cancer (NSCLC). Use of concurrent chemotherapy and radiotherapy is considered the gold standard in the treatment of locally advanced NSCLC but clinical outcomes are not satisfactory. Introduction of new radiotherapy technology and chemotherapy regimens are under investigation in this setting with the goal to improve unsatisfactory results. We report how radiotherapy is changing in the treatment of locally advanced NSCLC.
authors.affiliation: a Radiation Oncology Department , Sacro Cuore-Don Calabria Hospital , Negrar-Verona , Italy.
authors.forename: Niccoló
authors.initials: N
authors.lastname: Giaj-Levra
authors.affiliation: a Radiation Oncology Department , Sacro Cuore-Don Calabria Hospital , Negrar-Verona , Italy.
authors.forename: Francesco
authors.initials: F
authors.lastname: Ricchetti
authors.affiliation: a Radiation Oncology Department , Sacro Cuore-Don Calabria Hospital , Negrar-Verona , Italy.
authors.forename: Filippo
authors.initials: F
authors.lastname: Alongi
mesh_terms: D002289:Carcinoma, Non-Small-Cell Lung / Q000401:mortality / Q000473:pathology / Q000532:radiotherapy*; D059248:Chemoradiotherapy / Q000639:trends*; D004059:Diffusion of Innovation; D005544:Forecasting; D006801:Humans; D008175:Lung Neoplasms / Q000401:mortality / Q000473:pathology / Q000532:radiotherapy*; D011829:Radiation Dosage; D011878:Radiotherapy / Q000639:trends; D016896:Treatment Outcome
keywords: Altered fractionation; Dose escalation; Locally advanced; New technology; Non small cell lung cancer; Radiotherapy